Embody, Inc. specializes in advanced soft tissue healing technologies, focusing on the development of biointegrative solutions for orthopedic injuries. Their flagship product, the TAPESTRY Biointegrative Implant, utilizes a highly aligned and porous architecture made from type I bovine collagen, specifically designed to enhance tendon and ligament repair. This innovative implant creates an optimal microenvironment for healing, addressing the biological and structural challenges often faced in soft tissue procedures. Additionally, the TAPESTRY RC Arthroscopic Delivery and Fixation System represents a significant advancement in rotator cuff repair, combining a biointegrative implant with bioabsorbable fixation for effective arthroscopic delivery.

The company leverages cutting-edge manufacturing techniques, including electrospinning and microfluidic extrusion, to produce its collagen-based biologic products. These technologies enable Embody to create highly organized and porous microfibrous devices that enhance biomechanical performance while promoting healing. Their proprietary BIOSPIN technology is integral to the TAPESTRY implant, allowing for effective soft tissue augmentation. With a strong emphasis on scientific innovation, Embody aims to improve healing rates and outcomes in various orthopedic procedures, including those related to the knee, foot, ankle, and shoulder.

United States

Embody, Inc. is a commercial-stage company pioneering the next generation in collagen-based tendon and ligament healing for the fast-growing sports medicine market. Founded in 2014, the company is developing unique biomaterials with an initial focus on orthopedic applications including Achilles, rotator cuff and knee ligament repair.

Embody, Inc.

Company Details